These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10669174)

  • 21. Antibodies against annexin A5: detection pitfalls and clinical associations.
    Bozic B; Irman S; Gaspersic N; Kveder T; Rozman B
    Autoimmunity; 2005 Sep; 38(6):425-30. PubMed ID: 16278147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid antibodies: lessons from the bench.
    Koike T; Bohgaki M; Amengual O; Atsumi T
    J Autoimmun; 2007; 28(2-3):129-33. PubMed ID: 17383159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
    Matsuura E
    Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behçet's disease with vascular involvement: the contribution of anticardiolipin antibodies and thrombomodulin.
    Nakano H; Oka H; Matsuda T; Ooka S; Imamura Y; Suzuki T; Yamasaki Y; Itoh G; Azuma K; Ozaki S
    Adv Exp Med Biol; 2003; 528():395-8. PubMed ID: 12918732
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antibodies to beta2-glycoprotein-1 in patients with systemic lupus erythematosus].
    Borodin AG; Baranov NG; Nasonov EL
    Klin Med (Mosk); 2001; 79(2):49-51. PubMed ID: 11419087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein S deficiency and antibodies to protein S in patients with Behçet's disease.
    Guermazi S; Hamza M; Dellagi K
    Thromb Res; 1997 May; 86(3):197-204. PubMed ID: 9175241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
    Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
    Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-beta2-glycoprotein I and anti-annexin A5 antibodies.
    Gaspersic N; Ambrozic A; Bozic B; Majhenc J; Svetina S; Rozman B
    Rheumatology (Oxford); 2007 Jan; 46(1):81-6. PubMed ID: 16820381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cross sectional study of antiphospholipid-protein antibodies in patients with venous thromboembolism.
    Pasquier E; Amiral J; de Saint Martin L; Mottier D
    Thromb Haemost; 2001 Aug; 86(2):538-42. PubMed ID: 11522000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of activity of lupus anticoagulants.
    Rao LV
    Curr Opin Hematol; 1997 Sep; 4(5):344-50. PubMed ID: 9288468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated anti-annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities.
    Ogawa H; Zhao D; Dlott JS; Cameron GS; Yamazaki M; Hata T; Triplett DA
    Am J Clin Pathol; 2000 Oct; 114(4):619-28. PubMed ID: 11026109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta2-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of beta2-glycoprotein I.
    McNeeley PA; Dlott JS; Furie RA; Jack RM; Ortel TL; Triplett DA; Victoria EJ; Linnik MD
    Thromb Haemost; 2001 Aug; 86(2):590-5. PubMed ID: 11522008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
    Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
    Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study of 1038 pregnancies on the predictive value of anti-annexin V antibodies for fetal loss.
    Bizzaro N; Antico A; Musso M; Platzgummer S; Camogliano L; Tozzoli R; Villalta D
    Ann N Y Acad Sci; 2005 Jun; 1050():348-56. PubMed ID: 16014551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticardiolipin and anti-beta2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus.
    Tarkun I; Hacihanefioğlu A; Tarkun P; Cetinarslan B; Cantürk Z
    Diabetes Res Clin Pract; 2005 Jun; 68(3):181-7. PubMed ID: 15936458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-annexin V antibodies: are they prothrombotic?
    Esposito G; Tamby MC; Chanseaud Y; Servettaz A; Guillevin L; Mouthon L
    Autoimmun Rev; 2005 Jan; 4(1):55-60. PubMed ID: 15652780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adamantiades-Behçet's disease, deep venous thrombosis and anticardiolipin antibodies: report of two cases.
    Kandolf-Sekulovic L; Pavlovic MD; Glisic B; Petronijevic M; Ristic G; Mijuskovic Z; Zecevic RD; Stefanovic D
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):484-6. PubMed ID: 15987300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombosis associated with the prothrombin G-->A20210 mutation in Behçet's disease.
    Salvarani C; Calamia K; Silingardi M; Ghirarduzzi A; Olivieri I
    J Rheumatol; 2000 Feb; 27(2):515-6. PubMed ID: 10685825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.